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Abstract: Smoking, laryngopharyngeal reflux, and vocal fold abuse can promote the development 
of Reinke’s oedema, leading to vocal fold dysfunction and injury. The aim of the work was to 
investigate the appearance and distribution of proliferation marker Ki-67 (Ki-67), interleukin 10 (IL-
10), interleukin 1 alpha (IL-1α), and protein gene peptide 9.5 (PGP 9.5) in Reinke’s oedema-affected 
larynx tissue. Methods: A routine histological and immunohistochemical Reinke’s oedema and 
control group patient analysis was conducted. We used the biotin–streptavidin biochemical method 
to detect Ki-67, IL-10, IL-1α, and PGP 9.5 The semiquantitative grading method was used to evaluate 
immunoreactive cells' appearance and local distribution. A Mann–Whitney U test and Spearman’s 
rank coefficient were performed. Results: A low positive correlation between IL-1α epithelial and 
subepithelial immunoreactive cells in the patient group was found. Mann–Whitney U tests revealed 
significant patient and control group immunoreactive marker differences. All examined markers 
showed a higher number of immunoreactive structures in the patient group. Conclusions: Intensive 
proliferation of the surface epithelium was observed in patient tissues. The notable increase in IL-
10 positive structures indicates the dominant anti-inflammatory tissue response. An increased 
number of IL-1α structures in the larynx epithelium and subepithelium in the patient group is 
linked to inflammation, proliferation, and tissue remodelling. The PGP 9.5 expression increase is 
involved in the morphopathogenesis of Reinke’s oedema. 
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1. Introduction 
Reinke’s oedema (RE) is the benign diffuse swelling of the vocal folds, also known as 
various polypoid degeneration or smokers’ polyps. These lesions can be unilateral as well as 
bilateral [1]. The general population prevalence of Reinke’s oedema is 3.47/1000 [2]. Changes 
appear in the superficial lamina propria (SLP), also called Reinke’s space, which has an 
important functional role in vocal fold vibrations as well as voice production [3]. 
Reinke’s space consists of regularly interrelated parallel connective tissue fibres. An 
accumulation of the oedematous transudate in Reinke’s space can lead to varying levels 
of dysfunction of the vocal folds. During the phonation process, the oedematous 
transudate is in motion. The overexpression of the glottic wave created by Reinke’s 
oedema results in a deep, unmodulated voice [3,4]. Reinke’s oedema causes the voice to 
become hoarse, which causes patients to complain of vocal problems [2,5]. 
Smoking is considered the main risk factor for Reinke’s oedema; however, 
laryngopharyngeal reflux and vocal fold abuse also contribute to the development of this 
condition. It must be noted that allergies are not considered a crucial factor in the 
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aetiology of Reinke’s oedema [6–9]. The probability of suffering from Reinke’s oedema is 
higher in older women (>39 years old), but a predilection in males has also been found by 
some authors [2,10]. 
Various morphological changes can be found in Reinke's oedema, such as 
subepithelial vascularization, thickened basement membrane, dilated capillaries, dense 
reticular fibres around the vessels, inflammatory cell infiltration, elongated intracellular 
junctions, and widening of intracellular spaces [11,12]. 
Risk factors for Reinke’s oedema can lead to vocal fold injury. The reaction of the vocal 
fold mucosa due to the damage may be excessive extracellular matrix production. A strict 
correlation between the nuclear protein Ki-67 and cell proliferation has been found [13]. 
Proliferation marker Ki-67 (Ki-67) expression is high in proliferating cells and absent in resting 
cells [14]. Thus, for the determination of the cell growth fraction, Ki-67 is used, and Ki-67 
staining intensity is increased from the onset of the S phase until metaphase [15]. 
In cases of vocal fold trauma, the inflammatory response has been demonstrated to 
play a major role in the removal of injured tissue and reactions with invading organisms. 
Wound healing initially starts with the inflammatory stage, in which the recruitment of 
inflammatory cell infiltration, synthesis of growth factors and cytokines, and blood flow 
changes occur; this means that inflammatory inhibitors, including cytokines, are very 
important. B cells, mast cells, eosinophils, macrophages, and many subsets of T cells 
produce interleukin 10 (IL-10), which is widely known for its anti-inflammatory 
properties [16,17]. 
The damage of the tissue can promote the initiation of morphological alterations as 
well as cytokine release. IL-10 has an essential role in the regulation of immune responses, 
limiting the host immune response, preventing damage, and maintaining homeostasis 
[18]. Tissue motion can trigger an increase in IL-10 concentration [19]. Interestingly, 
average normalized IL-10 concentrations have been detected to be the highest 24 h after 
resonant voice exercises and the lowest after vocal rest [16]. 
One of the major proinflammatory interleukin-1 (IL-1) family members is interleukin 
1 alpha (IL-1α). Two main proinflammatory forms of IL-1 are IL-1α and IL-1β, whose 
effects are mediated through the IL-1R1 receptor. Healthy individual mesenchymal-
originated cells constitutively contain the IL-1α precursor [20–22]. The IL-1α precursor is 
localized in the cytosol and the nucleus, where it is bound to chromatin [23]. The release 
of IL-1α from macrophages is triggered by necrotic cells in vitro. The blockage of IL-1α 
influences the acute neutrophilic response but has barely any effects on monocytes. IL-1α 
necrotizing cells stimulate neutrophil infiltration [24]. 
Another important immunohistochemical marker is protein gene peptide 9.5 (PGP 
9.5), which is also known as ubiquitin C-terminal hydrolase (UCHL-1). PGP 9.5 has 
demonstrated ubiquitin carboxy-terminal ethyl esterase activity, and PGP 9.5 is known to 
be widely used as a neural and neuroendocrine cell marker [25–28]. 
The aim of this study was to investigate the distribution and appearance of Ki-67, IL-1α, 
IL-10, and PGP 9.5 in Reinke’s oedema-affected larynx tissue compared with control tissue. 
2. Materials and Methods 
2.1. Characteristics of the Subjects 
This study was approved by the Ethical Committee of Riga Stradins University. The 
approval was issued on 31.10.2019 (no. 6-2/2/25). We examined five vocal fold samples 
from patients with Reinke’s oedema (1 male and 4 females) aged 58 to 71 years (all were 
irregular smokers). The control group included 2 males and 5 females aged 50 to 75 years. 
We evaluated seven larynx tissue samples that were obtained from the control group 
during postmortem autopsies. Control tissue samples were obtained approximately at the 
same time as the patient tissue. All samples were stained simultaneously. The fixation and 
embedding method were the same. The control samples used for this study were the 
property of the Institute for Anatomy and Anthropology of Riga Stradins University. 
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2.2. Routine Histological Analysis 
The biopsy samples were fixed for 24 h with 2% formaldehyde and 0.2% picric acid 
in 0.1 M phosphate (pH = 7.2). After fixation, Tyrode’s buffer was applied to biopsy tissue 
for 12 h and then embedded into paraffin. Four-micrometre-thick sections were cut and 
stained with haematoxylin and eosin. This staining was used to evaluate tissue 
morphological structure. 
2.3. Immunohistochemical Analysis 
For the detection of Ki-67, PGP 9.5, IL-10, and IL-1α, the biotin–streptavidin 
biochemical method was used. Rabbit antibodies were used for the detection of Ki-67 
(CMC27531040, diluted 1:100, Sigma-Aldrich, St. Louis, MO, USA), IL-10 (orb100193, 
diluted 1:600, Biorbyt, Ltd., Cambridge, UK), PGP 9.5 (439273A, diluted 1:100, Zymed 
Laboratories, Invitrogen Corporation, Carlsbad, CA, USA), and IL-1α (orb308737, diluted 
1:100, Biorbyt Ltd.). 
The evaluation of immunoreactive cells in larynx tissue in ten random visual fields 
at ×400 (ocular ×10, objective ×40) was performed. Ki-67 immunoreactive cells were 
counted in ten randomly selected visual fields at ×400. In order to avoid subjectivity, the 
evaluation was performed by two researchers. For further data analysis, the median value 
was used. The slides were examined under a light microscope (Leica DC 300F, Leica 
Biosystems Richmond, Richmond, VA, USA). Image-Pro Plus 6.0 software (Media 
Cybernetics, Inc., Rockville, MD, USA) was used for image analysis. 
2.4. Quantification of Immunoreactive Cells 
To evaluate of the appearance and local distribution of IL-10, IL-1α, and PGP 9.5 
immunoreactive structures, a semiquantitative grading method was used [28–30]. The 
semiquantitative scoring system was labelled as follows: 0, negative staining (0%); 0/+, 
occasional positive structures (12.5%); +, few positive structures (25%); +/++, few to a 
moderate number of positive structures (37.5%); ++, moderate number of positive 
structures (50%); ++/+++, moderate to numerous positive structures (62.5%); +++, 
numerous positive structures (75%); +++/++++, numerous to abundant positive structures 
(87.5%); ++++, an abundance of positive structures (up to 100%) in the visual field [31]. 
2.5. Statistical Analysis 
For statistical analysis of the data, nonparametric statistical methods were used. For 
the analysis of the IL-10-, IL-1α-, PGP 9.5-, and Ki-67-positive structures within the larynx 
samples from patients with Reinke’s oedema and controls, the Mann–Whitney U test was 
used [30,32]. 
The collected data were transformed to SPSS as follows: negative staining, 0; 
occasional stained structures, 0.5; few stained structures, 1.0; few to moderate number of 
stained structures, 1.5; moderate number of stained structures, 2.0; moderate to numerous 
stained structures, 2.5; numerous stained structures, 3.0; numerous to abundant stained 
structures, 3.5; and abundant stained structures, 4.0. 
Spearman’s rank correlation coefficient rs (Spearman’s rho) was calculated for the 
evaluation of the cross-compliance of two variables [33]. The acquired correlation 
coefficient (rs) results were interpreted as follows: 0.80–1.00, very high; 0.60–0.80, high; 
0.40–0.60, moderate; 0.20–0.40, low; and <0.2 very low correlation. Statistically significant 
values were considered p values of ≤0.05. Statistical analysis of the data was performed 
using the statistical software SPSS v22.0 (IBM Co., North Castle, Armonk, NY, USA). 
  




3.1. Findings of Routine Histological Analysis 
Having examined the larynx tissue from the patients with Reinke’s oedema, various 
degrees of basal cell hyperplasia and thickening of the basement membrane were found. 
Intraepithelial infiltration was detected in three patient samples, while the infiltration in 
the control group was not predominant (Figure 1A,B). 
  
Figure 1. (A) No morphological changes were found in larynx mucosa of the control group. Hae-
matoxylin and eosin, ×200. (B) Note the basal cell hyperplasia and the thickening of basal membrane 
in the patient group. Haematoxylin and eosin, ×200. 
3.2. Immunohistochemistry Findings 
In all patient samples, Ki-67-positive structures were observed. Ki-67 displayed a me-
dian value of 140.5 positive epithelial cells in the patient group, but in the control group, 
Ki-67 was absent (Table 1, Figure 2A,B).  
IL-10 presented a stable expression of moderate to numerous positive structures both 
in the epithelium and the subepithelium in the patient group tissues. IL-10 was almost 
absent in the epithelium and the subepithelium of the control group tissues, marking oc-
casional immunoreactive cells (Table 1, Figure 2C,D). 
The patient group presented a high fluctuation in epithelial IL-1α expression, observ-
ing few to abundant IL-1α positive structures in visual fields. Moderate to numerous IL-
1α positive structures were noted both in the epithelium and the subepithelium in the 
patient group; however, the control group demonstrated occasional findings (Table 1, Fig-
ure 2E,F). IL-10 and IL-1α were expressed in Reinke’s oedema-affected larynx epithelium 
and subepithelium equally, showing moderate to numerous immunoreactive cells.  
Although the median value for PGP 9.5 expression in epithelial neuroendocrine cells 
(NEC) of the patient group was few to moderate positive structures, high fluctuations in 
expression were noted, in which the expression differed from occasional positive to nu-
merous positive structures. Meanwhile, the PGP 9.5 expression in epithelial NEC tissue of 
the control group showed stable expression across all subjects, showing occasional posi-
tive immunoreactive structures. A notable increase in PGP 9.5 was noted in the epithelial 
tissue, whereas subepithelial tissue showed fewer positive structures of PGP 9.5 subepi-
thelial nerves in the patient group; however, controls revealed a stable number of occa-
sional PGP 9.5 immunoreactive structures, epithelial as well as subepithelial. (Table 1, 
Figure 2G,H). 
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Figure 2. (A) Almost no positive Ki-67 structures were found in the control group. Ki-67, ×200. (B) 
Note Ki-67 positive cells in the patient group. Ki-67, ×200. (C) Note 0/+ positive number of IL-10 
positive structures in the epithelium and subepithelium of the control group. IL-10, ×200. (D) IL-10 
marks ++/+++ immunoreactive epithelial and subepithelial cells in the patient. IL-10; ×200. (E) 0/+ 
positive IL-1α epithelial and subepithelial structures in the control. IL-1α, ×200. (F) ++/+++ IL-1α 
immunoreactive structures in the epithelium and subepithelium of the patient. IL-1α, ×200. (G) 0/+ 
PGP 9.5 epithelial NEC and PGP 9.5 subepithelial nerve appearance in the control group. PGP 9.5, 
×200. (H) +/++ number of PGP 9.5 positive epithelial NEC and + positive subepithelial nerves in the 
patient group. PGP 9.5, ×200. Abbreviations: Ki-67—proliferation marker, IL-10 —interleukin 10, 
IL-1α —interleukin 1 alpha, PGP 9.5 —protein gene peptide 9.5; NEC —neuroendocrine cells. 
0/+—occasional positive structures, +—few positive structures, +/++—few to a moderate number of 
positive structures, ++/+++—moderate to numerous positive structures. 
Table 1. Median number of Ki-67 positive cells and median values of the semiquantitative evalua-



















P1 229.0 ++/+++ ++/+++ ++ ++/+++ +/++ + 
P2 140.5 ++/+++ ++/+++ ++/+++ ++/+++ +/++ +/++ 
P3 139.0 ++/+++/+++ ++/+++ ++/+++ ++/+++ +/++ + 
P4 204.5 ++/+++ ++/+++ ++/+++ ++/++/+++ +/+/++ + 
P5 126.0 ++/+++ ++/+++ ++/+++ ++/+++ +/++ +/++ 
Median (P) 140.5 ++/+++ ++/+++ ++/+++ ++/+++ +/++ + 
IQR (P) 84.25 0.125 0.00 0.25 0.125 0.125 0.5 
C1 0.00 0/+ 0/+ 0/+ 0/+ 0 0/+/+ 
C2 0.00 0/+ 0/+ 0/0/+ 0/+ 0/+ 0/+ 
C3 0.00 0/+ 0/+ 0/+ 0/+ 0 0/+ 
C4 0.00 0/+ 0/+ 0 0/+ 0/+ 0/+ 
C5 0.00 0/0/+ 0/+ 0/+ 0/+ 0/0/+ 0/+ 
C6 0.00 0/+ 0/+ 0/+ 0/+ 0/+ 0/+ 
C7 0.00 + 0/+ 0/+ 0/+ 0/+ 0/+ 
Median (C) 0.00 0/+ 0/+ 0/+ 0/+ 0/+ 0/+ 
IQR (C) 0.00 0.00 0.00 0.25 0.00 0.5 0.00 
Abbreviations: Ki-67—proliferation marker, IL-10 —interleukin 10, IL-1α —interleukin 1 alpha, 
PGP 9.5 —protein gene peptide 9.5, NEC —neuroendocrine cells. P1–P5—median value in each 
patient sample, C1–C7—median value in each control sample, Median (P)—median value in the 
patient group sample, Median (C)—median value in the control group sample, IQR (P)—inter-
quartile range in the patient group sample, IQR (C)—interquartile range in the control group sam-
ple, 0—negative staining, 0/0/+—between no positive structures and occasional positive structures, 
0/+—occasional positive structures, 0/+/+—between occasional positive structures and few positive 
structures, +—few positive structures, +/+/++—between few positive structures and few to a mod-
erate number of positive structures, +/++—few to a moderate number of positive structures, ++—
moderate number of positive structures, ++/++/+++—between a moderate number of structures and 
moderate to numerous positive structures, ++/+++—moderate to numerous positive structures, 
++/+++/+++—between moderate to numerous positive structures and numerous positive structures 
in the visual field. 
3.3. Statistical Analyses 
The following statistically significant differences were found between the patient and 
control groups: Ki-67 epitheliocytes (Mann–Whitney U: 0; Z-score: −3.169; p-value: 0.002), 
IL-10 epitheliocytes (Mann–Whitney U: 0; Z-score: −3.004; p-value: 0.003), IL-10 subepi-
thelial cells (Mann–Whitney U: 0; Z-score: −3.317; p-value: 0.001), IL-1α epitheliocytes 
(Mann–Whitney U: 0; Z-score: −3.004; p-value: 0.003), IL-1α-positive subepithelial cells 
(Mann–Whitney U: 0; Z-score: −3.24; p-value: 0.001), PGP 9.5-positive epithelial NEC 
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(Mann–Whitney U: 0; Z-score: −2.952; p-value: 0.003), and PGP 9.5 positive subepithelial 
nerves (Mann–Whitney U: 0; Z-score: −3.064; p-value: 0.002). 
Spearman’s rank coefficient revealed a low positive correlation between IL-1α epi-
thelial and IL-1α subepithelial immunoreactive cells in the patient group [rs = 0.285; p = 
0.045].  
4. Discussion 
In this study, the comparison of immunoreactive structures between the patient and 
the control group was performed to determine the significance of Ki-67, IL-10, IL-1α, and 
PGP 9.5 in the development of Reinke’s oedema. All examined markers in Reinke’s oe-
dema-affected larynx tissue revealed statically significant (p < 0.05) changes between the 
patients and the controls, with a higher number of immunoreactive positive structures in 
the patient tissue.  
Of all examined markers, only Ki-67 showed no expression in the epithelium of the 
control tissue. We assume that the Ki-67 expression differences between the patients and 
controls may be explained by proliferative changes. The increased Ki-67 expression find-
ings in patients reflect an active proliferative process, which could be caused by continu-
ous inflammation in larynx tissue due to persistent risk factors, for instance, smoking. 
Reinke’s oedema-affected larynx tissue has higher proliferative activity than epithelial 
cells without oedema [4]. It should be noted that Ki-67 requires an active cell division cycle 
for its expression, explaining the absence of Ki-67 in the controls, as they were obtained 
during a postmortem autopsy. A reduction and lack of Ki-67 immunoreactive cells have 
been found in postmortem material, as proliferation does not occur [13–15,34,35]. 
Statically significantly higher epithelial and subepithelial IL-10 expression in patients 
in comparison with the controls suggests that IL-10 plays an important role in the devel-
opment of Reinke’s oedema. Not only IL-1α but also IL-10 is involved in the regulation of 
neutrophil infiltration during the inflammatory process. We assume that IL-10 expression 
is related to the limitation of tissue damage due to anti-inflammatory properties by sup-
pressing proinflammatory cytokines, while elevated IL-1α expression indicates inflamma-
tion in patients. Additionally, IL-10 expression is related to the phonation process, as the 
tissue motion triggers IL-10 expression. These aspects may explain the higher IL-10 ex-
pression in our patients. Notably, prolonged phonation could damage the vocal folds, 
stimulating inflammation and IL-1α expression, thus indirectly repeatedly stimulating IL-
10 expression [17–19,24]. 
Reinke’s oedema-affected larynx epithelium and subepithelium revealed a higher ex-
pression of IL-1α than those in the control tissue samples. We suggest that proinflamma-
tory cytokine IL-1α expression in patients could be higher because of cellular stress-asso-
ciated factors as well as cell damage. A wide spectrum of possible stimuli could promote 
these expression changes; for instance, a direct effect of airflow on the larynx, microbial 
contamination, inhaled particles, and extensive vocal exercise may constitutively increase 
IL-1α expression, thus promoting inflammation. A higher intensity of phonation has 
caused increased expression of inflammatory mRNA in normal rabbit vocal folds [36]. 
Additionally, during routine histological examination, intraepithelial infiltration was 
noted in the samples of the patient group. The patient group presented a low positive 
correlation between IL-1α epithelial and IL-1α subepithelial immunoreactive cells, sug-
gesting that changes in the epithelium and subepithelium of Reinke’s oedema-affected 
larynxes are interacting. 
This observation supports the concept that IL-1α release might be related to cell in-
jury. In accordance with other authors, theoretically, this cytokine may be used as an in-
dicator for tissue health. Notably, elevated levels of IL-1α expression are also related to 
epithelial proliferation, loss of cell attachment, and cellular apical migration. It could mod-
ulate larynx tissue proliferation and remodelling processes. IL-1α is released from cells 
because of cell death or injury. We hypothesized that increased IL-1α in Reinke’s oedema 
is connected to persistent inflammation, proliferation, and tissue remodulation [37,38]. 
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Reinke’s oedema-affected larynx tissue revealed significantly higher PGP 9.5 epithe-
lial NEC as well as subepithelial expression in the patient group. Studies have shown that 
excess neuropeptides lead to an increase in immune infiltrates, which can promote the 
remodelling process. Therefore, we suggest that increased PGP 9.5 expression of patients 
could be a result of persistent inflammation and chronic irritation of environmental fac-
tors, which was also observed by other scientists [39]. 
Finally, we presume that Ki-67, IL-10, IL-1α, and PGP 9.5 play a role in the develop-
mental process of the morphopathogenesis in Reinke’s oedema. These immunoreactive 
markers could be involved in inflammation, proliferation, and remodelling of the larynx. 
5. Conclusions 
Reinke’s oedema-affected larynx tissue shows intensive proliferation of the surface 
epithelium; this could be due to persistent environmental factors (smoking) and inflam-
mation. The notable increase in IL-10-positive structures indicates the dominant anti-in-
flammatory tissue response. 
An increased number of IL-1α structures in the larynx epithelium and subepithelium 
in the patient group is linked to inflammation, proliferation, and tissue remodelling. PGP 
9.5 expression increase is involved in the morphopathogenesis of Reinke’s oedema. 
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